Search results for: Netherlands
Filter search results
Around The World in HTAs: The Netherlands – 5 Routes for New Tech
24 May 2023
…of pharmaceuticals in the Netherlands There are two assessment procedures for outpatient pharmaceuticals in the Netherlands: Procedures to allow entry onto the Dutch market: these procedures take place via the…
A Market-based International Reference Price Index: Solution or Contradiction?
13 September 2019
…basket, excluding Denmark and the Netherlands for lack of data, giving a total of 16 comparator countries. The analysis notes that Medicare Part B “could achieve significant savings if prices…
Risk Adjusting Health Care Resource Allocations
1 December 1999
…the practical application of risk adjustment in England, The Netherlands and Germany, which facilitated an up to date description of these systems at the time of writing. Thus, the health…
Access Mechanisms for Orphan Drugs: A Comparative Study of Selected European Countries
1 November 2009
This study compares pricing and reimbursement (P&R) policy for 43 orphan medicinal products (OMPs) across seven EU Member States: France, Germany, Italy, The Netherlands, Spain, Sweden and the UK. Examined…
Cost-effectiveness Analysis of Gene Therapies for Inherited Eye Disease: Are Current Discounting Approaches Too Short-sighted?
15 February 2023
…costs, including Belgium1, the Netherlands2, and Poland3. FIGURE 1: DISCOUNT RATES IN NATIONAL GUIDELINES FOR HEALTH ECONOMIC EVALUATIONS Sources: Canada4, France5, Belgium1, Germany6, Italy7, Singapore8, Denmark9, England10, Netherlands2, Norway11, Portugal12,…
Data Governance Arrangements for Real-World Evidence in Japan
1 September 2019
…Italy, Sweden, the Netherlands, the UK and the US1. Two years later, Lilly commissioned a second report based on the South Korean setting, following the same method and structure as…
Press Release: Proposed International Price Index Effectively Outsources Pharmaceutical Policy Decisions to Other Countries
29 October 2019
…A variant has been proposed that replaces Canada, Finland, Greece, Italy, Spain, Sweden, and the United Kingdom with Denmark, the Netherlands, Singapore, and Switzerland on the basis that they are…
Professor Lotte Steuten Appointed OHE Vice President and Head of Consulting
8 January 2019
…at the University of Washington, Seattle. She is also co-founder and Chief Scientific Officer of Panaxea bv, a health innovation consultancy firm with offices in the Netherlands, Belgium and Germany….
Access to Orphan Drugs in the EU
21 October 2010
…late September. The OHE study compares P&R policy for 43 OMPs across seven EU Member States: France, Germany, Italy, The Netherlands, Spain, Sweden and the UK. In particular, the study…